440 Deaths in Los Angeles County Reported Due to January 2025 Wildfires
By Elana Gotkine HealthDay Reporter

TUESDAY, Aug. 12, 2025 -- An estimated 440 deaths from Jan. 5 to Feb. 1, 2025, in Los Angeles County were attributable to the Los Angeles wildfires, according to a research letter published online Aug. 6 in the Journal of the American Medical Association.
Noting that 30 direct fatalities were reported in two major wildfires that impacted Los Angeles County in January 2025, Eugenio Paglino, Ph.D., from the University of Helsinki, and colleagues estimated excess deaths attributable to the Los Angeles wildfires. Weekly all-cause death counts were extracted by county of residence for Los Angeles County. The model was fitted on data from 2018, 2019, and 2024, excluding 2020 to 2023. Excess deaths were calculated as the difference between observed and expected deaths, and population-attributable fractions were calculated as excess death divided by observed deaths.
The researchers found that weekly deaths consistently exceeded expected deaths during the period from Jan. 5 to Feb. 1, 2025, in Los Angeles County. A total of 6,371 deaths were observed versus 5,931 expected deaths. In Los Angeles County, 6.9 percent of the observed deaths (440 deaths) were excess deaths. Excluding selected causes of death had little impact on the results; slightly more conservative estimates were seen with use of an alternative, controlled interrupted time series design; the number of excess deaths was increased when including data from 2023.
"The findings from this study underscore the need to complement direct fatalities estimates with alternative methods to quantify the additional mortality burden of wildfires and of climate-related emergencies more broadly," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-13 06:00
Read more

- CDC Says COVID-19 Cases Rising in 25 States
- Antiseizure Meds With Known or Uncertain Risks Continue to Be Prescribed in Pregnancy
- Remote CBT-Based Therapy Yields Modest Improvements in Chronic Pain
- Potentially Dangerous Modifications to E-Cigarettes Common
- Pierre Fabre Pharmaceuticals Inc. Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Tabelecleucel for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
- Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions